Last reviewed · How we verify

NCT05929508

Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss

Recruiting now NA Last updated 17 November 2025
What this trial tests

NA trial testing Ischemic Preconditioning in Traumatic Amputation of Lower Extremity in 30 participants. Currently enrolling.

Timeline
1 April 2024
Primary endpoint
1 June 2027
31 December 2027

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment30
Start date1 April 2024
Primary completion1 June 2027
Estimated completion31 December 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

18 and older, any sex, with Traumatic Amputation of Lower Extremity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the relationship between thigh strength and walking ability and assess if using a blood pressure cuff on the leg improves strength and walking performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ischemic Preconditioning

Trials testing the same drug.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05929508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing